首页   按字顺浏览 期刊浏览 卷期浏览 CI‐911: A placebo‐controlled study in patients with primary degenerative dementia
CI‐911: A placebo‐controlled study in patients with primary degenerative dementia

 

作者: Maurice W. Dysken,   Susan Anton‐Johnson,   Linda Klein,   Michael Kuskowski,   Lawrence J. Schut,   Steven H. Miles,   Gabe J. Maletta,   Richard De Jong,  

 

期刊: Drug Development Research  （WILEY Available online 1988）
卷期: Volume 12, issue 3‐4  

页码: 267-270

 

ISSN:0272-4391

 

年代: 1988

 

DOI:10.1002/ddr.430120309

 

出版商: Wiley Subscription Services, Inc., A Wiley Company

 

关键词: Alzheimer's disease;nootropic;clinical trial

 

数据来源: WILEY

 

摘要:

AbstractTwenty patients with primary degenerative dementia participated in a 6‐week, doseranging, double‐blind, placebo‐controlled study of Cl‐911, a cognition activator that enhances performance in animal models of impaired cognition. Cl‐911 was well tolerated in these patients, but it did not result in significant improvement on objective measures of cognition, social functioning, or

 

点击下载:  PDF (258KB)



返 回